Of relevance to the current topic, these beneficial anabolic outcomes is thought to result from BMP-7 antagonism of TGF-β, as TGF-β is implicated as major driver of catabolism in the progression of osteoarthritis (Cui et al. 2016; Long et al. 2016). The gene discussed is BMP7; the disease is osteoarthritis.